GLI1 genotypes do not predict basal cell carcinoma risk: a case control study

被引：0
|
作者：
Andrea Watson
Paul Kent
Murad Alam
Amy S Paller
David M Umbach
Joon Won Yoon
Philip M Iannaccone
David O Walterhouse
机构：
[1] University of Minnesota,Department of Pediatrics
[2] Rush University Medical Center,Department of Pediatrics
[3] Northwestern University Feinberg School of Medicine,Department of Dermatology
[4] National Institutes of Health,Biostatistics Branch, National Institute of Environmental Health Sciences
[5] Northwestern University,Department of Pediatrics, Feinberg School of Medicine and the Developmental Biology Program of the Children's Memorial Research Center
来源：
Molecular Cancer | / 8卷
关键词：
Basal Cell Carcinoma; Skin Type; Fitzpatrick Skin Type; Polytomous Logistic Regression; Automate Sequence Analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] GLI1 genotypes do not predict basal cell carcinoma risk: a case control study
    Watson, Andrea
    Kent, Paul
    Alam, Murad
    Paller, Amy S.
    Umbach, David M.
    Yoon, Joon Won
    Iannaccone, Philip M.
    Walterhouse, David O.
    MOLECULAR CANCER, 2009, 8
  • [2] Dual degradation signals control Gli1 protein stability and basal cell carcinoma formation
    Huntzicker, E.
    Estay, I.
    Zhen, H.
    Lokteva, L.
    Jackson, P.
    Oro, A. E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 17 - 17
  • [3] Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma
    Gerhard Regl
    Graham W Neill
    Thomas Eichberger
    Maria Kasper
    Mohammed S Ikram
    Josef Koller
    Helmut Hintner
    Anthony G Quinn
    Anna-Maria Frischauf
    Fritz Aberger
    Oncogene, 2002, 21 : 5529 - 5539
  • [4] Response of basal cell carcinoma to imiquimod was associated with the Gli1: Gli3 expression ratio
    Kanzaki, A.
    Kato, Y.
    Kariya, T.
    Kanda, Y.
    Shirai, K.
    Arai, T.
    Tsuboi, R.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (06) : 1406 - 1407
  • [5] Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma
    Regl, G
    Neill, GW
    Eichberger, T
    Kasper, M
    Ikram, MS
    Koller, J
    Hintner, H
    Quinn, AG
    Frischauf, AM
    Aberger, F
    ONCOGENE, 2002, 21 (36) : 5529 - 5539
  • [6] FOXM1 is a downstream target of Gli1 in basal cell carcinomas
    Teh, MT
    Wong, ST
    Neill, GW
    Ghali, LR
    Philpott, MP
    Quinn, AG
    CANCER RESEARCH, 2002, 62 (16) : 4773 - 4780
  • [7] Molecular diagnosis of basal cell carcinoma and other basaloid cell neoplasms of the skin by the quantification of Gli1 transcript levels
    Hatta, N
    Hirano, T
    Kimura, T
    Hashimoto, K
    Mehregan, DR
    Ansai, S
    Takehara, K
    Takata, M
    JOURNAL OF CUTANEOUS PATHOLOGY, 2005, 32 (02) : 131 - 136
  • [8] Loss of protein kinase Cα expression may enhance the tumorigenic potential of Gli1 in basal cell carcinoma
    Neill, GW
    Ghali, LR
    Green, JL
    Ikram, MS
    Philpott, MP
    Quinn, AG
    CANCER RESEARCH, 2003, 63 (15) : 4692 - 4697
  • [9] Utility of GLI1 RNA Chromogenic in Situ Hybridization in Distinguishing Basal Cell Carcinoma From Histopathologic Mimics
    Menge, Tyler D.
    Durgin, Joseph S.
    Hrycaj, Steven M.
    Brent, Ashley A.
    Patel, Rajiv M.
    Harms, Paul W.
    Fullen, Douglas R.
    Chan, May P.
    Bresler, Scott C.
    MODERN PATHOLOGY, 2023, 36 (10)
  • [10] Drug resistance in basal cell carcinoma identifies the inner nuclear membrane as a critical GLI1 regulatory checkpoint
    Mirza, A.
    McKeller, S. A.
    Oro, A. E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S30 - S30
12345